Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Ismat Babiker, Awab K. Elnaeim, Mohamed K. Elnaeim, Awab H. Saad
Objective: The purpose of this study was to assess knowledge of Alzheimer's disease among medical students and healthcare providers in Sudan.
Methods: In this cross-sectional study conducted in Sudan from July to December 2020, we used Google forms to collect data from 212 medical students and healthcare providers using Alzheimer's Disease Knowledge Scale (ADKS). ADKS is a widely used validated instrument that measures what people know about Alzheimer's disease using a 30-item true/false questionnaire across seven critical knowledge domains: Risk factors, symptoms, assessment and diagnosis, disease trajectory, life impact, treatment, and management, and caregiving.
Results: Our studied population consisted of doctors (n=106), medical students (n=23), Nursing staff (n=09), and other hospital staff (n=74). 76.9% were females. When rating their knowledge from 0 to 10, our participants' mean value was 5.3 ± 2.1. Regarding ADKS, the mean knowledge score (out of 30) is 20.6 ± 2.8. Regarding ADKS domains, the best average scores were treatment and management 86.8%, followed by life impact 78.3%, assessment, and diagnosis 72.4%, course 71.5%, symptoms 62.7%, caregiving 59.2%, and risk factors 59%. We did not detect any significant association between the average overall score, occupation, source of information, or having a relative with Alzheimer's disease.
Conclusion: Specific knowledge deficits were observed in domains focusing on risk factors, symptoms, and caregiving for Alzheimer's disease.